Prognosis
Major U.S. Drugstore Chains Pull Zantac Amid Carcinogen Concern
- Health officials investigating carcinogen found in the drugs
- Walgreens store-brand generic Zantac recalled last week
This article is for subscribers only.
The three major U.S. pharmacy chains are removing versions of the heartburn drug Zantac from store shelves as health regulators investigate a probable carcinogen detected in the popular stomach drugs.
Walgreens Boots Alliance Inc. said Monday that it would pull all versions of the drug from its thousands of stores around the country. Rite Aid Corp. announced Monday that it would follow suit, removing branded and private-label versions of the drug. On Saturday, CVS Health Corp. said it would stop selling brand Zantac as well as its store-brand products.